Login / Signup

Biomarkers for Renal Cell Carcinoma Recurrence: State of the Art.

Michele MarchioniJuan Gomez RivasAnamaria AutranMoises SocarrasSimone AlbisinniMatteo FerroLuigi SchipsRoberto Mario ScarpaRocco PapaliaFrancesco Esperto
Published in: Current urology reports (2021)
A wide variety of biomarkers have been proposed. RCC biomarkers have been individuated in tumoral tissue, blood, and urine. A variety of molecules, including proteins, DNA, and RNA, warrant a good accuracy for RCC recurrence and progression prediction. Their use in prediction models might warrant a better patients' risk stratification. Future prognostic models will probably include a combination of classical features (tumor grade, stage, etc.) and novel biomarkers. Such models might allow a more accurate treatment and follow-up planification.
Keyphrases
  • renal cell carcinoma
  • newly diagnosed
  • high resolution
  • free survival
  • nucleic acid
  • replacement therapy
  • circulating tumor cells